Phosphodiesterase-5 inhibitor
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Phosphodiesterase-5 inhibitor, covering 2010-09-14 to 2025-12-05. Get the full timeline:
Most recent: Clinical Trial Update: SIRIUS - Initial Combination Therapy With an Endothelin Receptor Antagonist, a Phosphodiesterase-5 Inhibitor and Sotatercept in Patients With Newly Diagnosed Pulmonary Arterial Hypertension [Phase 2]